Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

vTv Therapeutics (VTVT) Other Non Operating Income: 2014-2025

Historic Other Non Operating Income for vTv Therapeutics (VTVT) over the last 7 years, with Sep 2025 value amounting to -$34,000.

  • vTv Therapeutics' Other Non Operating Income fell 140.00% to -$34,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $325,000, marking a year-over-year increase of 319.59%. This contributed to the annual value of $160,000 for FY2024, which is 110.69% up from last year.
  • As of Q3 2025, vTv Therapeutics' Other Non Operating Income stood at -$34,000, which was down 162.96% from $54,000 recorded in Q2 2025.
  • In the past 5 years, vTv Therapeutics' Other Non Operating Income ranged from a high of $1.8 million in Q1 2023 and a low of -$3.6 million during Q3 2023.
  • In the last 3 years, vTv Therapeutics' Other Non Operating Income had a median value of $54,000 in 2025 and averaged -$121,545.
  • Its Other Non Operating Income has fluctuated over the past 5 years, first tumbled by 1,003.23% in 2023, then spiked by 1,858.82% in 2024.
  • Over the past 5 years, vTv Therapeutics' Other Non Operating Income (Quarterly) stood at $634,000 in 2021, then slumped by 197.48% to -$618,000 in 2022, then surged by 102.75% to $17,000 in 2023, then spiked by 1,858.82% to $333,000 in 2024, then slumped by 140.00% to -$34,000 in 2025.
  • Its last three reported values are -$34,000 in Q3 2025, $54,000 for Q2 2025, and -$28,000 during Q1 2025.